Isopropanolic Cimicifuga racemosa is favorable on bone markers but neutral on an osteoblastic cell line

被引:14
作者
Angel Garcia-Perez, Miguel [2 ]
Pineda, Begona [2 ]
Hermenegildo, Carlos [2 ,3 ]
Tarin, Juan J. [4 ]
Cano, Antonio [1 ]
机构
[1] Univ Valencia, Fac Med, Dept Pediat Obstet & Gynecol, Valencia 46010, Spain
[2] Univ Valencia, Hosp Clin Univ, Res Fdn, Valencia 46010, Spain
[3] Univ Valencia, Dept Physiol, Valencia 46010, Spain
[4] Univ Valencia, Dept Funct Biol & Phys Anthropol, Valencia 46010, Spain
关键词
HORMONE REPLACEMENT THERAPY; BLACK COHOSH; POSTMENOPAUSAL WOMEN; ENDOTHELIAL-CELLS; PROSTACYCLIN; RALOXIFENE; TURNOVER; EXTRACT;
D O I
10.1016/j.fertnstert.2008.03.042
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Postmenopausal women treated with an isopropanolic extract of Cimicifuga racemosa underwent a decrease in the urinary concentration of N-telopeptides, a marker of bone resorption, and an increase in alkaline phosphatase, a marker of bone formation, at the third month of therapy. Serum from treated women did not modify the activity of alkaline phosphatase or the expression of three genes, runt-related transcription factor-2 (Runx-2), alkaline phosphatase, and osteocalcin, when added to the MC3T3-E1 osteoblastic cell line. (Fertil Steril (R) 2009; 91:1347-50. (C)2009 by American Society for Reproductive Medicine.)
引用
收藏
页码:1347 / 1350
页数:4
相关论文
共 14 条
[1]   Estrogen receptor agonists and immune system in ovariectomized mice [J].
Garcia-Perez, M. A. ;
Del Val, R. ;
Noguera, I. ;
Hermenegildo, C. ;
Pineda, B. ;
Martinez-Romero, A. ;
Cano, A. .
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2006, 19 (04) :807-819
[2]   Similar efficacy of low and standard doses of transdermal estradiol in controlling bone turnover in postmenopausal women [J].
Garcia-Perez, Miguel Angel ;
Moreno-Mercer, Jane ;
Tarin, Juan J. ;
Cano, Antonio .
GYNECOLOGICAL ENDOCRINOLOGY, 2006, 22 (04) :179-184
[3]   Physiological investigation of a unique extract of black cohosh (Cimicifugae racemosae rhizoma):: A 6-month clinical study demonstrates no systemic estrogenic effect [J].
Liske, E ;
Hänggi, W ;
Henneicke-Von Zepelin, HH ;
Boblitz, N ;
Wüstenberg, P ;
Rahlfs, VW .
JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE, 2002, 11 (02) :163-174
[4]  
Mahady Gail B, 2005, Treat Endocrinol, V4, P177, DOI 10.2165/00024677-200504030-00006
[5]   Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines [J].
Matsuzaki, Etsuko ;
Takahashi-Yanaga, Fumi ;
Miwa, Yoshikazu ;
Hirata, Masato ;
Watanabe, Yutaka ;
Sato, Noriharu ;
Morimoto, Sachio ;
Hirofuji, Takao ;
Maeda, Katsumasa ;
Sasaguri, Toshiyuki .
JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 (08) :1307-1316
[6]   Hormone replacement therapy modifies the capacity of plasma and serum to regulate prostacyclin and endothelin-1 production in human vascular endothelial cells [J].
Mikkola, T ;
Ranta, V ;
Orpana, A ;
Viinikka, L ;
Ylikorkala, O .
FERTILITY AND STERILITY, 1996, 66 (03) :389-393
[7]   Postmenopausal hormone replacement therapy - Scientific review [J].
Nelson, HD ;
Humphrey, LL ;
Nygren, P ;
Teutsch, SM ;
Allan, JD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (07) :872-881
[8]   Therapeutic dosages of raloxifene do not modify myeloperoxidase and F2α-isoprostane levels in postmenopausal women [J].
Oviedo, PJ ;
Hermenegildo, C ;
Tarín, JJ ;
Cano, A .
FERTILITY AND STERILITY, 2005, 84 (06) :1789-1792
[9]   Raloxifene promotes prostacyclin release in human endothelial cells through a mechanism that involves cyclooxygenase-1 and-2 [J].
Oviedo, PJ ;
Hermenegildo, C ;
Tarín, JJ ;
Cano, A .
FERTILITY AND STERILITY, 2005, 83 (06) :1822-1829
[10]   A triterpene glycoside from black cohosh that inhibits osteoclastogenesis by modulating RANKL and TNFα signaling pathways [J].
Qiu, Samuel X. ;
Dan, Chun ;
Ding, Li-Sheng ;
Peng, Shulin ;
Chen, Shao-Nong ;
Farnsworth, Norman R. ;
Nolta, Jan ;
Gross, Michael L. ;
Zhou, Ping .
CHEMISTRY & BIOLOGY, 2007, 14 (07) :860-869